REPORT ID 2756

EMEA (Europe, Middle East and Africa) Meningococcal Vaccines Market Report 2017

Publish Date
11-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the EMEA Meningococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Meningococcal Vaccines for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Meningococcal Vaccines market competition by top manufacturers/players, with Meningococcal Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    JN-International Medical
    Novartis International
    Sanofi
    Pfizer
    Baxter International
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Menactra
    Menomune

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Pneumonia
    Meningitis
    Bacteremia
    Others (Arthritis, Conjunctivitis, Urethritis)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Meningococcal Vaccines Market Report 2017
1 Meningococcal Vaccines Overview
    1.1 Product Overview and Scope of Meningococcal Vaccines
    1.2 Classification of Meningococcal Vaccines
        1.2.1 EMEA Meningococcal Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Meningococcal Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Menactra
        1.2.4 Menomune
    1.3 EMEA Meningococcal Vaccines Market by Application/End Users
        1.3.1 EMEA Meningococcal Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Pneumonia
        1.3.3 Meningitis
        1.3.4 Bacteremia
        1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
    1.4 EMEA Meningococcal Vaccines Market by Region
        1.4.1 EMEA Meningococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Meningococcal Vaccines (2012-2022)
        1.5.1 EMEA Meningococcal Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Meningococcal Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Meningococcal Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Meningococcal Vaccines Market Competition by Players/Manufacturers
        2.1.1 EMEA Meningococcal Vaccines Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Meningococcal Vaccines Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Meningococcal Vaccines Sale Price by Players (2012-2017)
    2.2 EMEA Meningococcal Vaccines (Volume and Value) by Type/Product Category
        2.2.1 EMEA Meningococcal Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Meningococcal Vaccines Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Meningococcal Vaccines Sale Price by Type (2012-2017)
    2.3 EMEA Meningococcal Vaccines (Volume) by Application
    2.4 EMEA Meningococcal Vaccines (Volume and Value) by Region
        2.4.1 EMEA Meningococcal Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Meningococcal Vaccines Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Meningococcal Vaccines Sales Price by Region (2012-2017)

3 Europe Meningococcal Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Meningococcal Vaccines Sales and Value (2012-2017)
        3.1.1 Europe Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
    3.2 Europe Meningococcal Vaccines Sales and Market Share by Type
    3.3 Europe Meningococcal Vaccines Sales and Market Share by Application
    3.4 Europe Meningococcal Vaccines Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Meningococcal Vaccines Sales Volume by Countries (2012-2017)
        3.4.2 Europe Meningococcal Vaccines Revenue by Countries (2012-2017)
        3.4.3 Germany Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.4 France Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.5 UK Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.6 Russia Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.7 Italy Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Meningococcal Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Meningococcal Vaccines (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Meningococcal Vaccines Sales and Value (2012-2017)
        4.1.1 Middle East Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
    4.2 Middle East Meningococcal Vaccines Sales and Market Share by Type
    4.3 Middle East Meningococcal Vaccines Sales and Market Share by Application
    4.4 Middle East Meningococcal Vaccines Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Meningococcal Vaccines Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Meningococcal Vaccines Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.4 Israel Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.5 UAE Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.6 Iran Meningococcal Vaccines Sales and Growth Rate (2012-2017)

5 Africa Meningococcal Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Meningococcal Vaccines Sales and Value (2012-2017)
        5.1.1 Africa Meningococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Meningococcal Vaccines Revenue and Growth Rate (2012-2017)
    5.2 Africa Meningococcal Vaccines Sales and Market Share by Type
    5.3 Africa Meningococcal Vaccines Sales and Market Share by Application
    5.4 Africa Meningococcal Vaccines Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Meningococcal Vaccines Sales Volume by Countries (2012-2017)
        5.4.2 Africa Meningococcal Vaccines Revenue by Countries (2012-2017)
        5.4.3 South Africa Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Meningococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Meningococcal Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Meningococcal Vaccines Manufacturers/Players Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Meningococcal Vaccines Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 JN-International Medical
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Meningococcal Vaccines Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 JN-International Medical Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Novartis International
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Meningococcal Vaccines Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Novartis International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Sanofi
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Meningococcal Vaccines Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Sanofi Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Pfizer
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Meningococcal Vaccines Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pfizer Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Baxter International
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Meningococcal Vaccines Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Baxter International Meningococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Meningococcal Vaccines Manufacturing Cost Analysis
    7.1 Meningococcal Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Meningococcal Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Meningococcal Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Meningococcal Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Meningococcal Vaccines Market Forecast (2017-2022)
    11.1 EMEA Meningococcal Vaccines Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Meningococcal Vaccines Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Meningococcal Vaccines Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Meningococcal Vaccines Price and Trend Forecast (2017-2022)
    11.2 EMEA Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Meningococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Meningococcal Vaccines Sales Forecast by Type (2017-2022)
    11.7 EMEA Meningococcal Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer